Journal
PATHOGENS
Volume 11, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/pathogens11121410
Keywords
Zika virus; placenta; immune response; innate immunity
Categories
Funding
- FAPERJ
- [E-26/211.907/2021]
Ask authors/readers for more resources
Zika virus is a vector-borne virus that can cause severe complications in pregnant women and newborns. Although there have been studies on the susceptibility of placenta cells to infection, the understanding of innate immune response is still limited.
Zika virus (ZIKV) is an arthropod-borne virus that belongs to the Flaviviridae family, genus Flavivirus and was first isolated 1947 in Uganda, Africa, from the serum of a sentinel Rhesus monkey. Since its discovery, the virus was responsible for major outbreaks in several different countries, being linked to severe complications in pregnant women, neonatal birth defects and the congenital zika syndrome. Maternal-fetal transmission of ZIKV can occur in all trimesters of pregnancy, and the role of the placenta and its cells in these cases is yet to be fully understood. The decidua basalis and chorionic villi, maternal-fetal components of the placenta, contain a rich immunological infiltrate composed by Hofbauer cells, mastocytes, dendritic cells and macrophages, primary cells of the innate immune response that have a role that still needs to be better investigated in ZIKV infection. Recent studies have already described several histopathological features and the susceptibility and permissiveness of placenta cells to infection by the Zika virus. In this review, we address some of the current knowledge on the innate immune responses against ZIKV, especially in the placenta.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available